NEWS

News Image

Blackfrog Raises $1.7m to Accelerate Innovation in Medical Cold Chain Systems

Redefining the Cold Chain Standard in Healthcare
Blackfrog Technologies, a med-tech company focused on precision refrigeration solutions for life sciences and healthcare, has raised $1.7 million in Pre-Series A funding. This round includes $1 million from the Global Innovation Fund (GIF), $350,000 from Rainmatter Capital, and a follow-on investment of $350,000 from the Manipal Education and Medical Group (MEMG). The funding will enable Blackfrog to scale its portfolio of intelligent cold chain systems that serve the pharmaceutical, diagnostics, and clinical research sectors. The company is currently expanding its commercial footprint across private healthcare markets, while continuing to support critical public health delivery systems.
GIF Investment Image

GIF Investment Director Lily Steele (left) and Blackfrog CEO Mayur Shetty with an Emvólio backpack.

Bridging the Cold Chain Gap Between Innovation and Access

Cold chain logistics are critical to modern healthcare. From vaccine distribution and diagnostic sample transport to biopharmaceuticals and research reagents, medical-grade refrigeration directly impacts safety, effectiveness, and compliance.

Blackfrog’s flagship product, Emvólio, is a compact, portable, and digitally enabled refrigeration system, engineered for medical-grade performance and compliance. It uses thermoelectric cooling, live temperature tracking, and data analytics to ensure traceability, precision, and stability across the cold chain.

Deployed across 800+ health centers in India, as well as in Nigeria and Kenya, Emvólio has demonstrated reliability in last-mile settings. Now, Blackfrog is translating that same performance into high-volume commercial markets—especially pharma logistics, diagnostics, and research environments that demand uncompromising temperature control.

What This Round Enables

With this funding, Blackfrog is set to:

  • Launch three new refrigeration products by FY 2025–26 for pharma logistics, diagnostic labs, and clinical research
  • Scale manufacturing capabilities to meet demand from private-sector clients
  • Build a commercial sales and distribution network across India
  • Invest in quality control, compliance, and team growth to serve regulated markets

“We’re building a pipeline of innovations that will broaden our cold chain portfolio beyond Emvólio. These upcoming products are designed specifically for diagnostics and pharma logistics,” said Mayur Shetty, CEO at Blackfrog.

“By next year, we’ll be manufacturing and deploying them at scale. This is a decisive step toward our long-term vision: becoming India’s market leader in medical refrigeration by 2030.”

What Our Leadership and Partners Are Saying

“Today, there are deep-rooted inefficiencies in medical cold chains. Current methods for transporting vaccines, insulin, biologics, and even corneal tissue suffer from inconsistent temperature control, compromising effectiveness and safety,” said Vishvesh Krishna, Investment Manager at Rainmatter Capital.

“Blackfrog’s advanced thermoelectric cooling technology addresses these gaps, ensuring precise, stable, and medical-grade cooling. Our support for Blackfrog is a bet on the future of healthcare logistics.”

“This investment not only reinforces our commitment to improving quality of public healthcare delivery systems but also is an amplification of our continued support to nurture ‘innovations for public good,’” said Mr. Harinarayan Sharma, Vice President at MEMG.

“The investment by GIF is a great endorsement of the power of innovation spearheaded by our Alumni and for an idea incubated at the University Technology Incubator platform,” said Dr. Santhosha Rao, CEO, Manipal Universal Technology Business Incubator (MUTBI).

“Our aim is to support Blackfrog’s growth by building its commercial sales track record and manufacturing, showing the company can convert pilot projects into larger order volumes, and also develop new product lines to serve new markets,” said Lily Steele, Investment Director at the Global Innovation Fund (GIF).

“Blackfrog is exactly the kind of business we seek to support through Thrive—our new climate-health fund focused on innovations that enhance public health in a warming world.”

“We are grateful to be part of the Thrive initiative — a collaborative effort between PATH and GIF,” said Donson Dsouza, COO of Blackfrog. “We’re especially thankful to PATH for their technical support as we work together to strengthen climate-resilient health systems.”

A Smarter Cold Chain for a Smarter Market

Blackfrog’s solutions go beyond cooling—they bring data-driven control, regulatory compliance, and supply chain transparency to healthcare delivery. This funding round will support the company’s expansion into commercial segments that demand high reliability, such as vaccine logistics, diagnostics, and research labs.

Let’s Build the Future of Medical Refrigeration

Blackfrog is actively seeking:

  • Pharma logistics and diagnostics partners
  • Product distribution collaborations
  • Technology and healthcare alliances

Contact- info@blackfrog.in